Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
MGCD-265-analog is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity
8-19-10-17-9-18-19)12-5-4-11(15)7-13(12)16/h4-5
Ten micromoles per liter Oxyphenisatin acetate treatment results in autophagy and mitochondrial dysfunction
30)17-10-11-21(32-4)23(12-17)33-5)22(14-20(19)27(2)24(26)28)34-16-8-6-15(31-3)7-9-16/h6-14
1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine 714 MGCD-265-analog is an orally bioavailable1 Stearoyl 2 linoleoyl sn glycero 3 phosphocholine is an endogenous metabolite. Product information CAS Number: 27098 24 4 Molecular Weight: 786. 11 Formula: C44H84NO8P Chemical Name: trimethyl(2 {[(2R) 2 [(9Z,12Z) octadeca 9,12 dienoyloxy] 3 (octadecanoyloxy)propyl phosphonato]oxy}ethyl)azanium Smiles: C[N+](C)(C)CCOP([O ])(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCC C=C\C C=C\CCCCC InChiKey: FORFDCPQKJHEBF VPUSDGANSA N InChi: InChI=1S
US$ 116.00
US$ 91.00
US$ 203.50
US$ 59.96
US$ 100.50
US$ 271.00